Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 11 | $276,321 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 18 Mar 2025 12:27 | APLS | Apellis Pharmaceuticals Inc | CHOPAS JAMES GEORGE | VP/Chief Accounting Officer | 17 Mar 2025 | Sale | 183 | 24.8237 | 4,543 | D |
| 23 Jan 2025 15:19 | APLS | Apellis Pharmaceuticals Inc | CHOPAS JAMES GEORGE | VP/Chief Accounting Officer | 22 Jan 2025 | Sale | 1,096 | 30.4255 | 33,346 | D |
| 21 Jan 2025 15:56 | APLS | Apellis Pharmaceuticals Inc | CHOPAS JAMES GEORGE | VP/Chief Accounting Officer | 17 Jan 2025 | Sale | 715 | 29.9582 | 21,420 | D |
| 14 Jan 2025 16:09 | APLS | Apellis Pharmaceuticals Inc | CHOPAS JAMES GEORGE | VP/Chief Accounting Officer | 13 Jan 2025 | Sale | 783 | 28.7021 | 22,474 | D |
| 17 Sep 2024 16:08 | APLS | Apellis Pharmaceuticals Inc | CHOPAS JAMES GEORGE | VP/Chief Accounting Officer | 16 Sep 2024 | Sale | 192 | 36.206 | 6,952 | D |
| 04 Sep 2024 16:07 | APLS | Apellis Pharmaceuticals Inc | CHOPAS JAMES GEORGE | VP/Chief Accounting Officer | 03 Sep 2024 | Sale | 550 | 39.491 | 21,720 | D |
| 18 Mar 2024 16:19 | APLS | Apellis Pharmaceuticals Inc | CHOPAS JAMES GEORGE | VP/Chief Accounting Officer | 15 Mar 2024 | Sale | 184 | 56.461 | 10,389 | D |
| 23 Jan 2024 18:00 | APLS | Apellis Pharmaceuticals Inc | CHOPAS JAMES GEORGE | VP/Chief Accounting Officer | 22 Jan 2024 | Sale | 1,061 | 64.996 | 68,961 | D |
| 17 Jan 2024 16:45 | APLS | Apellis Pharmaceuticals Inc | CHOPAS JAMES GEORGE | VP/Chief Accounting Officer | 16 Jan 2024 | Sale | 864 | 66.8086 | 57,723 | D |
| 24 Oct 2023 16:20 | APLS | Apellis Pharmaceuticals Inc | CHOPAS JAMES GEORGE | VP/Chief Accounting Officer | 23 Oct 2023 | Sale | 132 | 46.0362 | 6,077 | D |
| 01 Sep 2023 16:08 | APLS | Apellis Pharmaceuticals Inc | CHOPAS JAMES GEORGE | VP/Chief Accounting Officer | 31 Aug 2023 | Sale | 551 | 41.226 | 22,716 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)